title: Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.
authors.affiliation: Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. asood@mdanderson.org
authors.forename: Anil K
authors.initials: AK
authors.lastname: Sood
authors.forename: Robert L
authors.initials: RL
authors.lastname: Coleman
authors.forename: Judith K
authors.initials: JK
authors.lastname: Wolf
authors.forename: David M
authors.initials: DM
authors.lastname: Gershenson
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D018925:Chemokines / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control* / Q000601:surgery; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D018925:Chemokines